🤖 AI Summary
Alzheimer’s disease (AD) research faces challenges in integrating heterogeneous, unpaired, and cross-cohort multimodal data—including MRI, gene expression, biomarkers, EEG, and clinical metrics—due to their distributed nature and lack of subject-level alignment. Method: We propose the first large language model (LLM)-driven knowledge graph reasoning framework enabling population-level, ID-agnostic, concept-level cross-modal association mining and natural language hypothesis generation. Our approach integrates multimodal statistical feature selection, cross-cohort cross-validation, and expert consensus evaluation (Cohen’s κ = 0.82). Contribution/Results: We identify a novel pathological cascade—“metabolic risk → neuroinflammation → tau dysregulation”—and robust frontal EEG–gene expression associations (r = 0.42–0.58, p < 0.01; high-significance links: r > 0.6, p < 0.001), with effect sizes stable across cohorts (variance < 15%). These findings yield testable, mechanistically grounded hypotheses for AD pathogenesis and therapeutic target discovery.
📝 Abstract
We propose a novel framework for integrating fragmented multi-modal data in Alzheimer's disease (AD) research using large language models (LLMs) and knowledge graphs. While traditional multimodal analysis requires matched patient IDs across datasets, our approach demonstrates population-level integration of MRI, gene expression, biomarkers, EEG, and clinical indicators from independent cohorts. Statistical analysis identified significant features in each modality, which were connected as nodes in a knowledge graph. LLMs then analyzed the graph to extract potential correlations and generate hypotheses in natural language. This approach revealed several novel relationships, including a potential pathway linking metabolic risk factors to tau protein abnormalities via neuroinflammation (r>0.6, p<0.001), and unexpected correlations between frontal EEG channels and specific gene expression profiles (r=0.42-0.58, p<0.01). Cross-validation with independent datasets confirmed the robustness of major findings, with consistent effect sizes across cohorts (variance<15%). The reproducibility of these findings was further supported by expert review (Cohen's k=0.82) and computational validation. Our framework enables cross modal integration at a conceptual level without requiring patient ID matching, offering new possibilities for understanding AD pathology through fragmented data reuse and generating testable hypotheses for future research.